Hanada K, Sawamura D, Tamai K, Hashimoto I, Kobayashi S
Department of Dermatology, Hirosaki University School of Medicine, Japan.
J Invest Dermatol. 1997 May;108(5):727-30. doi: 10.1111/1523-1747.ep12292108.
Previously we showed a protective role of endogenous glutathione (GSH) in ultraviolet B (UVB) injury. Moderate UVB exposure to hairless mice receiving oral treatment with buthionine sulfoximine (BSO), an inhibitor of GSH synthesis, resulted in a greater number of SBCs in the epidermis. The evidence led to the hypothesis that increasing the level of endogenous GSH in the skin may reduce the skin damage caused by a high dose of UVB irradiation. Since systemic administration of a reduced form of GSH (reduced GSH) is understood to have poor permeability into the cells, in the current study we investigated transportability of esterified GSH and photoprotective effect of reduced GSH and the esterified derivative against UVB injury in vivo. Oral administration of esterified GSH revealed increased cutaneous GSH level more effectively than did reduced GSH. The number of sunburn cells (SBC) formed was significantly depressed in the skin exposed to UVB in mice treated with esterified GSH as compared with non-GSH- or reduced GSH-treated mice. The suppressive effect of esterified GSH was prominent in BSO-treated animals.
先前我们证明了内源性谷胱甘肽(GSH)在紫外线B(UVB)损伤中具有保护作用。对接受谷胱甘肽合成抑制剂丁硫氨酸亚砜胺(BSO)口服治疗的无毛小鼠进行适度UVB照射,会导致表皮中出现更多的晒伤细胞(SBC)。这一证据引发了这样一个假说,即提高皮肤内源性GSH水平可能会减少高剂量UVB照射引起的皮肤损伤。由于还原型谷胱甘肽(GSH)全身给药的细胞通透性较差,在本研究中,我们研究了酯化型GSH的转运能力以及还原型GSH及其酯化衍生物在体内对UVB损伤的光保护作用。口服酯化型GSH比还原型GSH更有效地提高了皮肤中的GSH水平。与未用GSH或还原型GSH处理的小鼠相比,用酯化型GSH处理的小鼠在接受UVB照射的皮肤中形成的晒伤细胞(SBC)数量显著减少。酯化型GSH的抑制作用在经BSO处理的动物中尤为明显。